
CMS targets Medicaid eligibility in new crackdown; Trump administration weighs cannabis rescheduling; consumer data reshapes HCP engagement – Morning Medical Update
Key Takeaways
- CMS is enhancing Medicaid and CHIP eligibility verification, using federal databases to ensure enrollees meet citizenship and immigration criteria.
- The Trump administration is considering reclassifying cannabis, which could ease tax burdens but maintain federal oversight and interstate commerce barriers.
The top news stories in medicine today.
The Centers for Medicare & Medicaid Services (CMS) has launched a nationwide effort to
President Donald Trump said his administration is considering reclassifying cannabis, with a decision expected in the coming weeks. Rescheduling marijuana from Schedule I to Schedule III could bring tax relief to licensed businesses by removing 280E restrictions, though federal oversight and interstate commerce barriers would remain. Industry leaders say the shift would modernize research rules and expand treatment options, while urging operators to prepare for stricter compliance under a federal framework.
The old sales-rep model is giving way to digital-first outreach, but health care marketers still risk treating providers as little more than prescribing profiles. A
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.